Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 83 institutions that hold shares in the stock, with a total of 123 Million shares, which have been reported (via 13F filing form) to have a value of $66.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
27,404,070
shares
|
$14 Million
0.69% of portfolio
|
Q1 2024
New holding
|
|
|
Long Focus Capital Management, LLC
San Juan, PR |
Feb 14, 2025 Q4 2024 |
20,494,393
shares
|
$10.5 Million
0.38% of portfolio
|
Q4 2024
Added 54.09%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
17,079,778
shares
|
$8.71 Million
0.66% of portfolio
|
Q2 2023
Reduced -0.0%
|
|
|
Two Seas Capital LP
Rye, NY |
Feb 14, 2025 Q4 2024 |
14,835,146
shares
|
$7.57 Million
1.31% of portfolio
|
Q4 2024
New holding
|
|
|
Baillie Gifford & CO
|
Jan 31, 2025 Q4 2024 |
11,819,095
shares
|
$6.03 Million
0.01% of portfolio
|
Q4 2024
Reduced 29.55%
|
|
|
Mpm Asset Management LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
5,555,461
shares
|
$2.83 Million
2.41% of portfolio
|
Q4 2023
Reduced 11.64%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
5,095,912
shares
|
$2.6 Million
0.41% of portfolio
|
Q2 2023
New holding
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,871,969
shares
|
$2.48 Million
0.17% of portfolio
|
Q4 2024
Reduced 51.28%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
2,862,330
shares
|
$1.46 Million
0.0% of portfolio
|
Q4 2024
Reduced 38.49%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
2,526,524
shares
|
$1.29 Million
0.0% of portfolio
|
Q4 2024
Added 52.51%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,483,468
shares
|
$1.27 Million
0.05% of portfolio
|
Q4 2024
Added 2.39%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,324,864
shares
|
$675,680
0.0% of portfolio
|
Q4 2024
Reduced 22.02%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
916,941
shares
|
$467,639
0.0% of portfolio
|
Q4 2024
Reduced 12.3%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
715,607
shares
|
$364,959
0.03% of portfolio
|
Q2 2023
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
529,123
shares
|
$269,852
0.0% of portfolio
|
Q4 2024
Added 1.25%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
510,216
shares
|
$260,210
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Rathbones Group PLC
Liverpool, X0 |
Feb 13, 2025 Q4 2024 |
432,818
shares
|
$220,737
0.0% of portfolio
|
Q4 2021
Reduced 0.02%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
400,079
shares
|
$204,040
0.0% of portfolio
|
Q4 2024
Added 0.83%
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
326,937
shares
|
$166,737
0.0% of portfolio
|
Q4 2024
Added 87.73%
|
|
|
Key Client Fiduciary Advisors, LLC
|
Jan 17, 2025 Q4 2024 |
255,359
shares
|
$130,233
0.07% of portfolio
|
Q3 2024
Reduced 3.27%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
193,757
shares
|
$98,816
0.0% of portfolio
|
Q2 2024
Reduced 33.12%
|
|
|
Lpl Financial LLC
Fort Mill, SC |
Feb 11, 2025 Q4 2024 |
183,479
shares
|
$93,574
0.0% of portfolio
|
Q4 2024
Added 106.49%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
175,052
shares
|
$89,276
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
141,744
shares
|
$72,289
0.0% of portfolio
|
Q4 2024
Added 7700.99%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
139,801
shares
|
$71,298
0.0% of portfolio
|
Q3 2024
Added 18.57%
|